Aug 6, 2026 05:03PM
Jun 26, 2026 08:01AM
Jun 25, 2026 08:03AM
May 7, 2026 04:27PM
Apr 17, 2026 08:31AM
Apr 16, 2026 06:11AM
Nov 13, 2025 05:34PM Vaxart (VXRT) Tops Q3 EPS by 3c
Oct 8, 2025 08:00AM
Sep 17, 2025 04:06PM
Aug 29, 2025 08:01AM
Aug 13, 2025 04:09PM
Jun 11, 2025 07:30AM
May 29, 2025 08:02AM
May 16, 2025 08:04AM Vaxart (VXRT) Approves Resolutions to Narrow Proposed Reverse Split Range and Proposes Reducing Authorized Shares at Future Stockholder Meeting
May 15, 2025 08:01AM
May 13, 2025 04:21PM
May 13, 2025 04:02PM
May 5, 2025 08:01AM
Apr 30, 2025 08:01AM
Mar 20, 2025 04:21PM
Mar 5, 2025 04:06PM Vaxart (VXRT) Announces Publication Demonstrating the Immunogenicity and Safety of its First-Generation Oral Pill Norovirus Vaccine Candidate in Elderly Adults
Feb 24, 2025 03:06PM
Feb 10, 2025 05:03PM
Jan 28, 2025 08:02AM
Jan 14, 2025 08:07AM
Nov 13, 2024 04:03PM
Aug 28, 2024 08:01AM
Aug 8, 2024 04:17PM Vaxart (VXRT) Tops Q2 EPS by 6c
Jun 17, 2024 04:06PM
Jun 17, 2024 05:13AM
Jun 14, 2024 07:35AM
Jun 14, 2024 05:59AM
Jun 14, 2024 04:39AM
Jun 13, 2024 05:01PM
Jun 13, 2024 04:15PM Vaxart (VXRT) Receives BARDA-Funded Award Valued Up to $453M for Phase 2b Study of COVID-19 Oral Pill Vaccine Candidate

431,651 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All